Biotech Showcase™ 2013 Press Releases

January 16, 2013Fifth annual Biotech Showcase™ in San Francisco saw record attendance1,600 life science investors and biopharma executives converge upon event
Biotech Showcase™ 2013 investor and partnering conference was held in San Francisco last week. The event welcomed private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives as well as other industry professionals. Held at Parc 55 Wyndham San Francisco - Union Square, the event featured 236 presenting ...more ►

January 3, 2013Innovative biotech companies and investors will gather at Biotech Showcase™ 2013 in San Francisco next week Biotech Showcase™ 2013 investor and partnering conference will welcome some of the sector's most innovative biotech companies to San Francisco on January 7–9. The event will be held at Parc 55 Wyndham San Francisco - Union Square, and is expected to draw over 1,000 executives from the life sciences. Attending comp...more ►

December 17, 2012Biotech Showcase™ 2013 in San Francisco January 7–9 features dynamic program geared toward life science investors Biotech Showcase™ 2013 investor and partnering conference, to be held January 7–9, 2013 in San Francisco, CA at Parc 55 Wyndham San Francisco - Union Square, is an innovation showcase for life science investors. This year's program kicks off on Monday, January 7 with parallel workshops. The first, entitled "The Wa...more ►

September 14, 2012Global biotech execs to converge on San Francisco January 7–9 for Fifth Annual Biotech Showcase™Biotech Showcase™ 2013 investor and partnering conference, to be held January 7–9, 2013 in San Francisco, CA at Parc 55 Wyndham San Francisco - Union Square, is an innovation showcase for life science investors. The event attracts executives from emerging private and public biotechnology and life science companies interested in presenting to raise their profile with potential inves...more ►

3 May 2013 Want success in China? Find an experienced Chinese partner “In China, unless you have deep resources, it is difficult to come and do everything yourself,” said Greg Scott of ChinaBio^®. “The market is fragmented, distribution is complex, and drug approval and pricing are complicated. It may take longer than in the West to bring a product to market, and business is conducted differently.” more ►

3 May 2013 China’s rapid growth nourishes biotech environment “Chinese investors haven’t lost a lot of money in biotech, so they’re in a good mood.” In the West, venture capital is drying up for life science firms so some small companies have come to Asia to raise financing where there is an available supply of money. more ►

3 May 2013 WuXi AppTec: “Every client is a partner” "Our vision is to create platforms so that anyone who wants to explore an idea can come and use the platform in their most effective way to push their idea and innovation. We are always being asked, 'Why don’t you become a pharma company?' But that’s not who we are. For us, it’s about being able to enable innovation across the board. We think it’s a very important mission." more ►

18 March 2013 A view from the West: Trends in biotech venture exits The last year in biotech saw a breakout from prior performance on multiple fronts across stocks, drug approvals, venture returns, and pharma investing. more ►

18 March 2013 Should we fund technology or people in early stage innovation? Is the value in translational research and preclinical programs to be found in the science or the people who are carrying forward a potential breakthrough? Three executives on the front lines of investing offer surprising insights. more ►